Board of Directors

Ivonne Cantú

Independent Non-executive Director

Election to the Board - Ivonne was appointed to the Board from 1 January 2022.

Career - Ivonne has significant public company experience having spent over 20 years advising listed businesses. She is currently the Director of Investor Relations, Communications and Sustainability as well as a member of the Executive management team and the Sustainability Committee of Benchmark Holdings Limited, a biotechnology aquaculture company. She is also a Non-executive Director and Chair of the Remuneration Committee at Creo Medical Group plc.

Skills, competence and experience - Prior to taking up her position at Benchmark Holdings Limited, Ivonne spent 13 years as a Senior Corporate Finance Adviser at Cenkos Securities plc, and prior to that seven years as an Investment Banker at Merrill Lynch. She has a degree in Engineering from the Universidad Panamericana in Mexico City and an MBA from the Wharton School of Business at the University of Pennsylvania.

Other listed directorships - Non-executive Director of Creo Medical Group plc.

Independent Non-executive - Yes

Mark Davies

Chief Executive Office

Election to the Board - Mark Davies will succeed Harry Hyman as CEO of the Group at the conclusion of the 2024 AGM.

Career - Mark was a Co-founder Director of NewRiver REIT plc (“NewRiver”) in 2009 and played an important role in taking NewRiver from IPO into the FTSE 250 index in seven years. He was CFO of NewRiver for over twelve years and, alongside his role as CFO, was also CEO/Executive Chairman of Hawthorn Leisure Limited (“Hawthorn”) for five years. Mark stood down from the Board of NewRiver following the successful sale of Hawthorn in July 2021 to private equity at a premium price.

Skills, competence and experience -  Mark has considerable capital markets experience and over the last fourteen years has raised over £3 billion of equity and debt in public and private markets.

Other listed directorships - Senior Independent Director of Palace Capital plc

Laure Duhot

Independent Non-executive Director

Election to the Board – Laure Duhot was appointed to the Board from 14 March 2019 following completion of the merger with MedicX Fund Limited, where she had also been a Non-executive Director. She is Chair of the ESG Committee.

Career – Laure started her career in the investment banking sector and has developed a focus on the property sector. She has held senior roles at Lehman Brothers, Macquarie Capital Partners, Sunrise Senior Living Inc., Grainger plc and Lendlease. She is a Non-executive Director of Safestore Holdings plc, NB Global Monthly Income Fund Limited and of Orpea S.A., a Paris-listed operator of retirement homes.

Skills, competence and experience – Laure brings over 30 years of senior executive level experience in the investment banking and property sectors, specialising in alternative real estate assets, and has been a Non-executive Director at a number of funds and property companies.

Other listed directorships – Non-executive Director of Safestore Holdings plc, Orpea S.A. and NB Global Monthly Income Fund Limited.

Independent Non-executive - Yes

Richard Howell

Chief Financial Officer

Election to the Board - Richard Howell was appointed to the Board from 31 March 2017, having joined Nexus on 13 March 2017 and, following completion of the internalisation of the advisory and management functions previously carried out by Nexus, he was appointed Chief Financial Officer.

Career - Richard is a Chartered Accountant and has over 20 years’ experience working with London-listed commercial property companies, gained principally with LondonMetric Property plc and Brixton plc. Richard was part of the senior management team that led the merger of Metric Property Investments plc and London & Stamford Property Plc in 2013 to create LondonMetric Property plc. In May 2022 he was appointed as a Non-executive Director at Life Science REIT plc, an AIM-listed externally managed real estate trust.

Skills, competence and experience - Richard has extensive finance experience, having previously held senior accounting positions within listed property companies operating across the UK. Whilst working for LondonMetric Property plc and Brixton plc, he has been involved in over £5 billion of property transactions.

Other listed directorships - Senior Independent Non-Executive Director and Audit
Chair of Life Science REIT plc.

Independent Non-executive - Not applicable

Harry Hyman

Chair

Election to the Board - Harry Hyman founded the Company in 1996 and served on the Board as Managing Director from that time and represented the former Adviser to the Company, Nexus Tradeco Limited (“Nexus”), on the Board. On completion of the internalisation on 5 January 2021, Harry was appointed as Chief Executive Officer. As announced on 2 November 2023, subject to shareholder approval Harry will be appointed as Non-executive Chair with effect from the end of the 2024 AGM. The Board believes that Harry’s appointment is in the best interests of the Group and all of its stakeholders, particularly as his knowledge and expertise gained over nearly 30 years in the primary care property sector will continue to be invaluable and highly relevant to the Group’s future success. The Board has determined that the term will be a maximum of three years.

Career - Harry graduated from Cambridge University and trained as a Chartered Accountant and Corporate Treasurer. He established the Company in 1996 and was the Managing
Director of Nexus Tradeco Limited, which until 5 January 2021 was the Adviser to PHP.
He is a Fellow of the Institute of Chartered Accountants in England and Wales, a Fellow of the Association of Corporate Treasurers and a Fellow of the Royal Institute of Chartered Surveyors.

Skills, competence and experience - Harry has extensive experience in investing in the primary healthcare sector, having developed the Company’s business from inception over 20 years ago to its current position with an investment portfolio of over £2.6 billion. He also brings entrepreneurial flair to the Board having established a number of successful private companies.

Other listed directorships - Non-executive Chairman of Biopharma Credit plc, an externally managed investment trust which invests in the fast-growing science industry, and is listed on the London Stock Exchange.

Independent Non-executive - Not applicable

Ian Krieger

Senior Independent Non-Executive Director

Election to the Board - Ian Krieger was elected a Director at the 2018 Annual General Meeting, having been appointed to the Board in February 2018, and is Chairman of the Audit Committee.

Career - Ian is a Chartered Accountant and was a Partner and Vice-Chair at Deloitte until his retirement in 2012. He is currently Senior Independent Non-executive Director and Chairman of the audit committee at Safestore Holdings plc and is Senior Independent Non-executive Director at Capital & Regional plc, where he is also the Chairman of the Audit Committee.

Skills, competence and experience - Ian qualified as and practised as a Chartered Accountant and brings a wealth of recent financial experience to the Board as well as his experience as Chairman of the audit committees of two other UK-listed companies in the property sector.

Other listed directorships - Non-executive Director of Safestore Holdings plc and Capital & Regional plc.

Independent Non-executive - Yes

Dr Bandhana (Bina) Rawal

Independent Non-executive Director

Election to the Board - Bina Rawal was appointed to the Board from 27 February 2024.

Career - Bina is a medical professional with 25 years' senior executive experience in healthcare, including with blue chip pharmaceutical companies such as Roche and global reseearch funding charity Wellcome Trust. She is currently Senior Independent Director at Worldwide Healthcare Trust plc, a FTSE 250-listed investment trust specialising in healthcare and life sciences companies where she is board lead for ESG and chairs the nominations committee. She is also a non-executive director of Central London Community Healthcare NHS Trust. 

Skills, competence and experience - Bina has a wide breadth of experience spanning patient care, digital and population health, ESG, strategy, partnerships and EDI, alongside extensive networks in UK healthcare through her senior level executive and non-executive roles to date in large, complex organisations within the public, private and not-for-profit sectors.

Other listed directorships - Worldwide Healthcare Trust plc

Independent Non-executive - Yes